Anulex Technologies has announced FDA has cleared its fiXate Tissue Band for additional indications for use, according to a news release.
The fiXate Tissue Band is intended to be an accessory to the leads/catheter component of spinal cord stimulator/pain pump systems functioning to secure the lead/catheter to the fascia or inter-spinous/supra-spinous ligament.
It previously received FDA clearance for securing spinal cord stimulation lead anchors to fascia or interspinous/supraspinous ligaments in patients with chronic, intractable pain of the trunk and/or limbs. The new indication allows for securing intrathecal pain pump catheters in the same tissue.
"With the expansion of indications for fiXate Tissue Band, Anulex continues to demonstrate its commitment to developing novel and clinically relevant solutions for soft tissue fixation and repair," said Jeff Peters, Anulex's CEO, in the release.
Related Articles on FDA Clearances:
Spacelabs Healthcare Receives FDA 510(k) Clearance for New Anesthesia Delivery System
Arkon Anesthesia Delivery System Receives 510(k) Clearance
FDA Approves Torax Medical Surgical Device to Treat GERD